Ebglyss (lebrikizumab-lbkz) - Eli Lilly
Successful treatment of Hailey-Hailey disease (HHD) with the IL-13 inhibitor lebrikizumab. (PubMed, J Dtsch Dermatol Ges) - Oct 24, 2026 - No abstract available 
Journal • Genetic Disorders • IL13
http://www.ncbi.nlm.nih.gov/pubmed/42908405
 
Elena Schneider; Maike M Holtsche; Nikolaos Patsinakidis; Ulrike Raap
 
Oct 24, 2026
 
Prev Next